Melatonin enhances arsenic trioxide-induced cell death via sustained upregulation of Redd1 expression in breast cancer cells-Reference-Cited by-同舟云学术

Melatonin enhances arsenic trioxide-induced cell death via sustained upregulation of Redd1 expression in breast cancer cells

Published:2016-02 Issue: Volume:422 Page:64-73
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Yun Sun-Mi^ORCID,Woo Sang Hyeok,Oh Sang Taek,Hong Sung-Eun,Choe Tae-Boo,Ye Sang-Kyu,Kim Eun-Kyu,Seong Min Ki,Kim Hyun-A,Noh Woo Chul,Lee Jin Kyung,Jin Hyeon-Ok,Lee Yun-Han,Park In-Chul

Funder

Ministry of Science, ICT & Future Planning

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference40 articles.

1. Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells;Alarifi;Onco Targets Ther.,2013

2. Introduction: the history of arsenic trioxide in cancer therapy;Antman;Oncologist,2001

3. Effect of melatonin and pineal extracts on human ovarian and mammary tumor cells in a chemosensitivity assay;Bartsch;Life Sci.,2000

4. Pro-oxidant effect of melatonin in tumour leucocytes: relation with its cytotoxic and pro-apoptotic effects;Bejarano;Basic Clin. Pharmacol. Toxicol.,2011

5. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex;Brugarolas;Genes Dev.,2004

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway;IUBMB Life;2024-08-30

2. Melatonin: Avenues in cancer therapy and its nanotechnological advancements;MedComm – Biomaterials and Applications;2023-09

3. The stress-responsive protein REDD1 and its pathophysiological functions;Experimental & Molecular Medicine;2023-09-01

4. Effect of capecitabine and melatonin on HER2+ (SK-BR-3) and HER2- (MCF7) human breast cancer cell lines;Tropical Journal of Pharmaceutical Research;2023-08-19

5. ChaC1-based drug screenings identify a synergistic lethal effect of auranofin and proteasome inhibitors in hepatocellular carcinoma cells.;2023-08-10